Bures Thomas
CIK 0001787029
Chief Financial Officer
Filings
5
Latest Feb 18, 2026
Issuers covered
2
Showing
5 of 5
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -13.1% | -13.1% | -13.1% | -13.1% |
| 90 days | 1 | 0% | -17.3% | -17.3% | -17.3% | -17.3% |
| 180 days | 1 | 0% | -35.0% | -35.0% | -35.0% | -35.0% |
| 365 days | 1 | 0% | -22.8% | -22.8% | -22.8% | -22.8% |
Issuers
Companies where Bures Thomas has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BRKR | Bruker Corp | 3 | Feb 18, 2026 |
| PIRS | Pieris Pharmaceuticals, Inc. | 2 | Feb 28, 2023 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|